Not exact matches
Although the antithrombin - based therapies for
haemophilia are not designed to completely block their targets, «knocking them down is not
without risk», he says.
Ghosh's research leads to the conclusion that a patient with
haemophilia who co-inherits a thrombophilic gene bleeds less than one
without that mutation.
The results, published in the New England Journal of Medicine, demonstrate the therapy being used to treat 10 male
haemophilia patients
without significant side effects.